Contact
Please use this form to send email to PR contact of this press release:
Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Proposed Biosimilar to Xolair® (Omalizumab)
TO:
Please use this form to send email to PR contact of this press release:
Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Proposed Biosimilar to Xolair® (Omalizumab)
TO: